Interview: Dwight Gorham – President & CEO, Pillar5 Pharma, Canada

Dwight Gorham, president and CEO of Pillar5 Pharma, discusses the unique positioning of the CDMO in the multi-dose preservative free sterile ophthalmics space and stresses the importance of anticipating market trends in order to fuel expansion. Finally, he gives an insight into the importance of honing new skills and how the regulated industry of pharma should not regulate one’s thinking. Can you introduce Pillar5 Pharma to our international audience?
"Between 2009 and 2014, the company experienced a 100 percent growth in sales and a 50 percent improvement in productivity"
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report